Checkpoint Therapeutics, Inc. Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2024
Form of Inducement Letter Agreement, dated as of October 2, 2023, by and between Checkpoint Therapeutics, Inc. and the Holder
Checkpoint Therapeutics, Inc.
Biotechnology
2023
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2023
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2022
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2021
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2020
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Checkpoint Therapeutics, Inc., dated June 14, 2018
Checkpoint Therapeutics, Inc.
Biotechnology
2018
First Amendment to Amended and Restated Founders Agreement
Checkpoint Therapeutics, Inc.
Biotechnology
2017
CHECKPOINTTHERAPEUTICS, INC. AMENDEDAND RESTATED 2015 INCENTIVEPLAN ARTICLE1 PURPOSE
Checkpoint Therapeutics, Inc.
Biotechnology
DE
2017
SECOND AMENDMENT TO SUBLICENSE AGREEMENT
Checkpoint Therapeutics, Inc.
Biotechnology
2017
FIRST AMENDMENT TO SUBLICENSE AGREEMENT
Checkpoint Therapeutics, Inc.
Biotechnology
2017
EXTENSION OF OPTION AGREEMENT
Checkpoint Therapeutics, Inc.
Biotechnology
2017
SECOND AMENDMENT TO EXECUTIVE EMPLOYMENTAGREEMENT
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2017